Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours (Q35703610)
Jump to navigation
Jump to search
scientific article published on February 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours |
scientific article published on February 2012 |
Statements
1 reference
Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours (English)
1 reference
A Frost
1 reference
K Mross
1 reference
S Steinbild
1 reference
S Hedbom
1 reference
C Unger
1 reference
R Kaiser
1 reference
D Trommeshauser
1 reference
G Munzert
1 reference
1 February 2012
1 reference
1 reference
19
1 reference
1
1 reference
e28-35
1 reference
1 February 2012
1 reference
Identifiers
1 reference
1 reference
1 reference